Log in to your Inderes Free account to see all free content on this page.

Orexo

19.92 SEK

Less than 1K followers

ORX

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Orexo

2019202020212022202320242025
Revenue844.8663.6565.0624.3638.8590.026.0
growth-%-21.4 %-14.9 %10.5 %2.3 %-7.6 %-95.6 %
EBITDA272.219.0-161.1-180.4-9.723.4772.3
EBIT231.2-19.9-214.1-183.9-109.5-140.3-352.7
Profit before taxes227.9-38.3-222.5-170.4-140.3-190.6-403.0
Net income219.1-84.4-223.5-177.6-128.3-203.0639.3
EPS6.33-2.44-6.51-5.17-3.73-5.8918.46
Dividend0.000.000.000.000.000.000.00
Dividend ratio0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %0.0 %
Login required

This content is only available for logged in users

Profitability and return on capital

2019202020212022202320242025
EBITDA-%32.2 %2.9 %-28.5 %-28.9 %-1.5 %4.0 %2,970.4 %
EBIT-%27.4 %-3.0 %-37.9 %-29.5 %-17.1 %-23.8 %-1,356.5 %
ROE31.0 %-15.1 %-63.9 %-91.6 %-217.8 %160.7 %130.3 %
ROI14.6 %-6.8 %-17.5 %-16.0 %-16.3 %-34.1 %49.1 %
Login required

This content is only available for logged in users